392 related articles for article (PubMed ID: 21808634)
1. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue.
Geurts L; Lazarevic V; Derrien M; Everard A; Van Roye M; Knauf C; Valet P; Girard M; Muccioli GG; François P; de Vos WM; Schrenzel J; Delzenne NM; Cani PD
Front Microbiol; 2011; 2():149. PubMed ID: 21808634
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
[TBL] [Abstract][Full Text] [Related]
3. Novel insights into the genetically obese (ob/ob) and diabetic (db/db) mice: two sides of the same coin.
Suriano F; Vieira-Silva S; Falony G; Roumain M; Paquot A; Pelicaen R; Régnier M; Delzenne NM; Raes J; Muccioli GG; Van Hul M; Cani PD
Microbiome; 2021 Jun; 9(1):147. PubMed ID: 34183063
[TBL] [Abstract][Full Text] [Related]
4. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db/db mice.
Everard A; Matamoros S; Geurts L; Delzenne NM; Cani PD
mBio; 2014 Jun; 5(3):e01011-14. PubMed ID: 24917595
[TBL] [Abstract][Full Text] [Related]
5. Exploring the endocannabinoidome in genetically obese (ob/ob) and diabetic (db/db) mice: Links with inflammation and gut microbiota.
Suriano F; Manca C; Flamand N; Depommier C; Van Hul M; Delzenne NM; Silvestri C; Cani PD; Di Marzo V
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jan; 1867(1):159056. PubMed ID: 34606993
[TBL] [Abstract][Full Text] [Related]
6. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice.
Everard A; Lazarevic V; Derrien M; Girard M; Muccioli GG; Neyrinck AM; Possemiers S; Van Holle A; François P; de Vos WM; Delzenne NM; Schrenzel J; Cani PD
Diabetes; 2011 Nov; 60(11):2775-86. PubMed ID: 21933985
[TBL] [Abstract][Full Text] [Related]
7. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans.
Dray C; Debard C; Jager J; Disse E; Daviaud D; Martin P; Attané C; Wanecq E; Guigné C; Bost F; Tanti JF; Laville M; Vidal H; Valet P; Castan-Laurell I
Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1161-9. PubMed ID: 20233941
[TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid system links gut microbiota to adipogenesis.
Muccioli GG; Naslain D; Bäckhed F; Reigstad CS; Lambert DM; Delzenne NM; Cani PD
Mol Syst Biol; 2010 Jul; 6():392. PubMed ID: 20664638
[TBL] [Abstract][Full Text] [Related]
9. Cholinergic drugs reduce metabolic inflammation and diabetic myocardial injury by regulating the gut bacterial component lipopolysaccharide-induced ERK/Egr-1 pathway.
Wu Q; Zhao M; Li D; He X; Zang W
FASEB J; 2023 May; 37(5):e22917. PubMed ID: 37039813
[TBL] [Abstract][Full Text] [Related]
10. Glucose metabolism: focus on gut microbiota, the endocannabinoid system and beyond.
Cani PD; Geurts L; Matamoros S; Plovier H; Duparc T
Diabetes Metab; 2014 Sep; 40(4):246-57. PubMed ID: 24631413
[TBL] [Abstract][Full Text] [Related]
11. A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese (
Suriano F; Manca C; Flamand N; Van Hul M; Delzenne NM; Silvestri C; Cani PD; Di Marzo V
Cells; 2023 Jan; 12(3):. PubMed ID: 36766753
[TBL] [Abstract][Full Text] [Related]
12. Effects of Exogenous Hydrogen Sulfide on Diabetic Metabolic Disorders in db/db Mice Are Associated With Gut Bacterial and Fungal Microbiota.
Liu J; Zhao W; Gao ZW; Liu N; Zhang WH; Ling H
Front Cell Infect Microbiol; 2022; 12():801331. PubMed ID: 35425717
[TBL] [Abstract][Full Text] [Related]
13. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
[TBL] [Abstract][Full Text] [Related]
14. Blockade of CB1 cannabinoid receptor alters gut microbiota and attenuates inflammation and diet-induced obesity.
Mehrpouya-Bahrami P; Chitrala KN; Ganewatta MS; Tang C; Murphy EA; Enos RT; Velazquez KT; McCellan J; Nagarkatti M; Nagarkatti P
Sci Rep; 2017 Nov; 7(1):15645. PubMed ID: 29142285
[TBL] [Abstract][Full Text] [Related]
15. Dietary Epigallocatechin-3-Gallate Alters the Gut Microbiota of Obese Diabetic
Park JM; Shin Y; Kim SH; Jin M; Choi JJ
J Med Food; 2020 Oct; 23(10):1033-1042. PubMed ID: 33054538
[TBL] [Abstract][Full Text] [Related]
16. Effect of dark sweet cherry powder consumption on the gut microbiota, short-chain fatty acids, and biomarkers of gut health in obese db/db mice.
Garcia-Mazcorro JF; Lage NN; Mertens-Talcott S; Talcott S; Chew B; Dowd SE; Kawas JR; Noratto GD
PeerJ; 2018; 6():e4195. PubMed ID: 29312822
[TBL] [Abstract][Full Text] [Related]
17. Impaired glucose metabolism and altered gut microbiome despite calorie restriction of ob/ob mice.
Kashani A; Brejnrod AD; Jin C; Kern T; Madsen AN; Holm LA; Gerber GK; Holm JC; Hansen T; Holst B; Arumugam M
Anim Microbiome; 2019 Sep; 1(1):11. PubMed ID: 33499919
[TBL] [Abstract][Full Text] [Related]
18. Gut Microbiota Mediates the Protective Effects of Dietary Capsaicin against Chronic Low-Grade Inflammation and Associated Obesity Induced by High-Fat Diet.
Kang C; Wang B; Kaliannan K; Wang X; Lang H; Hui S; Huang L; Zhang Y; Zhou M; Chen M; Mi M
mBio; 2017 May; 8(3):. PubMed ID: 28536285
[TBL] [Abstract][Full Text] [Related]
19. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.
Cani PD; Osto M; Geurts L; Everard A
Gut Microbes; 2012; 3(4):279-88. PubMed ID: 22572877
[TBL] [Abstract][Full Text] [Related]
20.
Xu Y; Wang N; Tan HY; Li S; Zhang C; Zhang Z; Feng Y
Theranostics; 2020; 10(24):11302-11323. PubMed ID: 33042284
[No Abstract] [Full Text] [Related]
[Next] [New Search]
